Swiss pharma company Roche is buying Flatiron Health for $1.9 billion

 Roche, the global pharmaceutical company from Switzerland, today announced it will scoop up Flatiron Health, a startup analyzing real-time oncology data to help cancer patients and doctors, in a $1.9 billion deal. Flatiron has also confirmed the deal to TechCrunch. Read More

Responses are currently closed, but you can trackback from your own site.

Comments are closed.